SK283077B6 - Chalkóny, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Chalkóny, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK283077B6
SK283077B6 SK1795-99A SK179599A SK283077B6 SK 283077 B6 SK283077 B6 SK 283077B6 SK 179599 A SK179599 A SK 179599A SK 283077 B6 SK283077 B6 SK 283077B6
Authority
SK
Slovakia
Prior art keywords
phenyl
hydroxy
propen
pyridyl
cme
Prior art date
Application number
SK1795-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK179599A3 (en
Inventor
Ezio Bombardelli
Piero Valenti
Original Assignee
Indena S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S. P. A. filed Critical Indena S. P. A.
Publication of SK179599A3 publication Critical patent/SK179599A3/sk
Publication of SK283077B6 publication Critical patent/SK283077B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
SK1795-99A 1997-06-19 1998-06-12 Chalkóny, farmaceutický prostriedok s ich obsahom a ich použitie SK283077B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9712966.2A GB9712966D0 (en) 1997-06-19 1997-06-19 Novel chalcones
PCT/EP1998/003558 WO1998058913A1 (en) 1997-06-19 1998-06-12 Chalcones having antiproliferative activity

Publications (2)

Publication Number Publication Date
SK179599A3 SK179599A3 (en) 2000-06-12
SK283077B6 true SK283077B6 (sk) 2003-02-04

Family

ID=10814591

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1795-99A SK283077B6 (sk) 1997-06-19 1998-06-12 Chalkóny, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (22)

Country Link
US (1) US6147082A (de)
EP (1) EP0989973B1 (de)
JP (1) JP4064471B2 (de)
KR (1) KR20010013603A (de)
CN (1) CN1198802C (de)
AT (1) ATE303362T1 (de)
AU (1) AU742784C (de)
CA (1) CA2294278C (de)
CZ (1) CZ294976B6 (de)
DE (1) DE69831409T2 (de)
DK (1) DK0989973T3 (de)
ES (1) ES2244075T3 (de)
GB (1) GB9712966D0 (de)
HK (1) HK1023770A1 (de)
HU (1) HU227628B1 (de)
NO (1) NO314802B1 (de)
PL (1) PL190495B1 (de)
PT (1) PT989973E (de)
RU (1) RU2203883C2 (de)
SI (1) SI0989973T1 (de)
SK (1) SK283077B6 (de)
WO (1) WO1998058913A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100711537B1 (ko) 2000-01-27 2007-04-27 다카라 바이오 가부시키가이샤 치료제
KR100377514B1 (ko) * 2000-05-23 2003-03-26 신국현 찰콘 유도체, 그의 제조방법 및 그를 포함하는 약학적조성물
DE10060677A1 (de) 2000-12-05 2002-06-20 Aventis Pharma Gmbh Klainetine und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
US7514579B2 (en) * 2002-06-13 2009-04-07 Johns Hopkins University Boronic chalcone derivatives and uses thereof
AU2003272902A1 (en) * 2002-10-01 2004-04-23 Takara Bio Inc. Remedies
KR101347830B1 (ko) * 2004-05-23 2014-01-07 에이치엠아이, 인코포레이티드 테라뮤틴 조절물질
CN100336797C (zh) * 2005-08-19 2007-09-12 浙江大学 四取代查耳酮衍生物及制备方法和用途
CN102060792B (zh) * 2010-12-24 2016-08-03 西南大学 2′-胺基查尔酮唑类化合物及其吡唑啉和环丙基唑类衍生物、制备方法与用途
ES2540457B2 (es) * 2013-06-19 2015-12-28 Universidad De Sevilla Procedimiento de obtención de extractos de hojas de Corema album y su aplicación terapéutica
CN103360338B (zh) * 2013-07-30 2015-04-01 中国科学院新疆理化技术研究所 一种查尔酮苯并噻唑酰胺类衍生物的制备方法和用途
CN103896932A (zh) * 2014-04-18 2014-07-02 山东药品食品职业学院 异恶唑基芳基查尔酮衍生物及其制备方法和应用
CN103910691A (zh) * 2014-04-18 2014-07-09 山东药品食品职业学院 卤代苯基查尔酮衍生物及其制备方法和应用
CZ307046B6 (cs) * 2015-09-02 2017-12-13 Univerzita PalackĂ©ho v Olomouci Komplexy mědi s deriváty (E)-1-(2´-hydroxyfenyl)-3-fenylprop-2-en-1-onu a jejich použití jako léčiv v protinádorové terapii
WO2017103637A1 (en) 2015-12-18 2017-06-22 Blirt S.A. Diphenylpropane compounds and their cytotoxic activity
CN106279082B (zh) * 2016-08-02 2019-02-01 浙江大学 取代的呋喃查耳酮类衍生物及其制备方法
CN111138264B (zh) * 2019-11-29 2023-08-04 温州医科大学 一种丁香醛衍生物及其在制备抗妇科肿瘤药物中的应用
KR102496887B1 (ko) * 2020-10-15 2023-02-06 경상국립대학교산학협력단 부테인 유도체 또는 이의 약학적으로 허용가능한 염을 포함하는 유방암의 예방, 개선 또는 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2084208A1 (en) * 1990-05-17 1991-11-18 Barry Markaverich Growth inhibitors and methods of treating cancer and cell proliferative diseases
IT1271301B (it) * 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono

Also Published As

Publication number Publication date
ATE303362T1 (de) 2005-09-15
CA2294278A1 (en) 1998-12-30
CN1198802C (zh) 2005-04-27
SI0989973T1 (sl) 2006-02-28
RU2203883C2 (ru) 2003-05-10
NO996287L (no) 2000-02-21
HUP0003068A3 (en) 2002-02-28
DK0989973T3 (da) 2005-10-17
PL337361A1 (en) 2000-08-14
CZ294976B6 (cs) 2005-04-13
HK1023770A1 (en) 2000-09-22
NO314802B1 (no) 2003-05-26
JP4064471B2 (ja) 2008-03-19
KR20010013603A (ko) 2001-02-26
CN1261349A (zh) 2000-07-26
AU8537598A (en) 1999-01-04
DE69831409D1 (de) 2005-10-06
HU227628B1 (en) 2011-10-28
WO1998058913A1 (en) 1998-12-30
GB9712966D0 (en) 1997-08-27
HUP0003068A2 (hu) 2001-01-29
SK179599A3 (en) 2000-06-12
ES2244075T3 (es) 2005-12-01
JP2002506439A (ja) 2002-02-26
NO996287D0 (no) 1999-12-17
EP0989973A1 (de) 2000-04-05
AU742784C (en) 2005-08-18
CZ459999A3 (cs) 2000-05-17
CA2294278C (en) 2007-09-25
DE69831409T2 (de) 2006-06-08
US6147082A (en) 2000-11-14
PL190495B1 (pl) 2005-12-30
AU742784B2 (en) 2002-01-10
PT989973E (pt) 2005-11-30
EP0989973B1 (de) 2005-08-31

Similar Documents

Publication Publication Date Title
SK283077B6 (sk) Chalkóny, farmaceutický prostriedok s ich obsahom a ich použitie
EP1749830A1 (de) Curcumolderivate, diese enthaltende zusammensetzungen und deren verwendung bei der herstellung eines medikaments
US6423740B1 (en) Chalcones having antiproliferative activity
CN109467549B (zh) 喹啉取代查尔酮类化合物、其制备方法及用途
RU2266291C2 (ru) Халконовые кумарины
CN110002987B (zh) 苯基亚烯丙基环己烯酮衍生物及制备方法和用途
AU2022201524A1 (en) Inhibitors of the n-terminal domain of the androgen receptor
CN108101943B (zh) 一种替诺福韦前药或可药用盐及其在医药上的应用
KR100819576B1 (ko) 신규 찰콘 화합물
HUT67899A (en) Thioxanthenone antitumor agents
KR101457637B1 (ko) 디히드로피라졸카르보티오아미드 유도체 및 그 제법 및 그 유도체를 포함하는 항암제 조성물
EP0123605B1 (de) N-Cyclopropylmethyl-2-oxo-3-diparamethoxyphenyl-5,6-triazin, Verfahren zu seiner Herstellung und seine Verwendung als Arzneimittel
TW528751B (en) Amino anthracyclinone derivatives used in the treatment of amyloidoses, process for preparing the same and pharmaceutical composition comprising the same
JPH05262760A (ja) チオキサンテノン類およびその抗腫瘍剤
FR2632641A1 (fr) ((aryl-4-piperazinyl-1)-2 ethoxy)-3 p-cymene, les derives ortho, meta, para monosubstitues ou disubstitues sur le noyau phenyle dudit produit, le procede de preparation desdits derives, et les medicaments contenant lesdits composes comme principe actif
EP0558321A1 (de) N-Cycloalkyl-Verbindungen mit antiviraler Wirkung
JPH0729921B2 (ja) 骨粗鬆症治療剤
JPH04330043A (ja) トリアリールエチレン誘導体及びそれを含有する腫瘍抑制作用を有する医薬組成物
Walker et al. Avery et a].(45) Date of Patent: Dec. 23, 2008
CN102675273A (zh) 3-芳基-8-烯丙基-7-羟基（甲氧基）香豆素及在制备抗肿瘤药物中的应用

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20120612